March 10 (Reuters) -

Digital physical therapy company Hinge Health, which

provides digital exercise therapy programs to help people manage

and overcome muscle and joint pain, on Monday filed for its

long-sought initial public offering in the United States.

The San Francisco, California-based company, which was

valued at $6.2 billion in a 2021 funding round, reported a 33.4%

increase in revenue for 2024 and a reduction in net losses

according to its IPO documentation.

Revenue rose to $390.4 million in 2024, compared with

$292.7 million a year earlier, while net losses shrunk to $11.9

million in the same period from $108.1 million a year earlier.

Hinge Health, along with some of its existing

shareholders, plans to sell shares in this proposed offering.

The IPO comes despite recent stock market volatility due

to President Trump's tariff policies and adds to the growing

momentum for healthcare listings.

Founded in 2014 by Daniel Perez and Gabriel Mecklenburg,

Hinge Health's platform provides comprehensive musculoskeletal

care ranging from acute injury treatment to chronic pain

management and post-surgical rehabilitation.

The company raised $400 million in 2021 in a Series E

financing round led by investment firms Tiger Global and Coatue

Management.

Other major shareholders include venture capital firm

Insight Venture Partners, Atomico, 11.2 Capital, and Bessemer

Venture Partners.

Morgan Stanley, Barclays and BofA Securities are the lead

underwriters for the offering.

Hinge Health will list on the New York Stock Exchange under

the symbol "HNGE."